CC-401 hydrochloride is primarily investigated for its potential in biomedical research, particularly as a kinase inhibitor. It has shown activity against certain protein kinases involved in cellular signaling pathways linked to inflammation and cancer progression. Due to its ability to modulate these pathways, it is used in preclinical studies to explore therapeutic strategies for oncology and inflammatory diseases. Its application is mainly confined to laboratory research where it helps elucidate kinase-dependent cellular mechanisms and assess target validation in disease models.